Point-of-Care Glucose Testing Market is predicted to reach USD 4.39 Bn by 2030

Point-of-Care Glucose Testing Market is predicted to reach USD 4.39 Bn by 2030According to the study by Next Move Strategy Consulting, the global Point of Care Glucose Testing Market size is predicted to reach USD 4. 39 Bn with a CAGR of 4. 4% by 2030. Request a FREE Sample: https: www. nextmsc. com point of care glucose testing market request sample The rapidly growing incidence of diabetes across the globe, driven by inactive lifestyles and unhealthy eating patterns, is significantly increasing the demand for point of care

According to the study by Next Move Strategy Consulting, the global Point-of-Care Glucose Testing Market size is predicted to reach USD 4.39 Bn with a CAGR of 4.4% by 2030.

Request a FREE Sample: https://www.nextmsc.com/point-of-care-glucose-testing-market/request-sample

The rapidly growing incidence of diabetes across the globe, driven by inactive lifestyles and unhealthy eating patterns, is significantly increasing the demand for point-of-care (POC) glucose testing.

Furthermore, the rise in the global aging population, who are more susceptible to diabetes and metabolic disorders, is driving the need for regular blood glucose monitoring.

North America dominates the point-of-care glucose testing market share due to favorable regulatory environment and approvals from agencies such as the FDA.

Various key players operating in the point of care glucose testing industry include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Dexcom Inc, EKF Diagnostics Holdings plc, Nipro Corporation, Nova Biomedical, ACON Laboratories, Inc., Trividia Health, Inc., LifeScan, Inc., AgaMatrix and others.